Bió-Phārmā: Ingredient

Novartis Japan Achieves Primary Endpoint In HER2 Positive Advanced Breast Cancer Phase III Afinitor Trials

Everolimus Novartis announced it achieved its primary endpoint of significantly extending progression-free survival with Afinitor (everolimu...

Artemisinin and its derivatives, such as Artemether, are highly sensitive compounds, which require careful optimized production processes fo...

Unemployment remains high in the U.S. and other countries, and yet manufacturers struggle to find the skilled workers they need. It’s a madd...

Researchers at the University of Leeds, funded by Cancer Research UK, suggest that people with very pale skin may be unable to spend enough ...

A jumping gene with the fairy tale name "Sleeping Beauty" has helped to unlock vital clues for researchers investigating the genet...

When deploying or upgrading Customer Relationship Management (CRM) systems, pharmaceutical companies have experienced varying degrees of su...

Lots of Exercise May Boost Kids' Grades A Dutch review of prior research reveals that the more physically active school-aged children ar...